Application

15291370 · Crystalline Forms of (s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl) piperidine-4-carboxamide

Filed 2016-10-12 · Granted · Patent 10039766 (2018-08-07) The official file ↗The patent and its PDF ↗ · Art unit 1628 · Examiner Anna Pagonakis Hard · CPC A61K 9/2013 · AstraZeneca AB · ASTRAZENECA MEDIMMUNE

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.2 mo

to disposition 21.8 mo

Statutes raised

102

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.